Ignite Creation Date:
2025-12-24 @ 2:40 PM
Ignite Modification Date:
2026-01-20 @ 11:10 PM
Study NCT ID:
NCT06261359
Status:
RECRUITING
Last Update Posted:
2024-09-04
First Post:
2024-02-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of CEND-1 With Chemotherapy as First-Line Therapy in Patients With Pancreatic Ductal Adenocarcinoma
Sponsor:
Qilu Pharmaceutical Co., Ltd.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Pancreatic Ductal Adenocarcinoma (PDAC) | View |
Keywords: